Due to the adjustable hybridization activity, antinuclease
digestion
stability, and superior endocytosis, spherical nucleic acids (SNAs)
have been actively developed as probes for molecular imaging and the
development of noninvasive diagnosis and image-guided surgery. However,
since highly expressed biomarkers in tumors are not negligible in
normal tissues, an inevitable background signal and the inability
to precisely release probes at the chosen region remain a challenge
for SNAs. Herein, we proposed a rationally designed, endogenous enzyme-activatable
functional SNA (Ep-SNA) for spatiotemporally controlled signal amplification
molecular imaging and combinational tumor therapy. The self-assembled
amphiphilic polymer micelles (SM-ASO), which were obtained by a simple
and rapid copper-free strain-promoted azide–alkyne cycloaddition
click reaction between dibenzocyclooctyne-modified antisense oligonucleotide
and azide-containing aliphatic polymer polylactic acid, were introduced
as the core elements of Ep-SNA. This Ep-SNA was then constructed by
connecting two apurinic/apyrimidinic (AP) site-containing trailing
DNA hairpins, which could occur via a hybridization chain reaction
in the presence of low-abundance survivin mRNA to SM-ASO through complementary
base pairing. Notably, the AP site-containing trailing DNA hairpins
also empowered the SNA with the feasibility of drug delivery. Once
this constructed intelligent Ep-SNA nanoprobe was specifically cleaved
by the highly expressed cytoplasmic human apurinic/apyrimidinic endonuclease
1 in tumor cells, three key elements (trailing DNA hairpins, antisense
oligonucleotide, and doxorubicin) could be released to enable subsequent
high-sensitivity survivin mRNA imaging and combinational cancer therapy
(gene silencing and chemotherapy). This strategy shows great application
prospects of SNAs as a precise platform for the integration of disease
diagnosis and treatment and can contribute to basic biomedical research.